Editor
Verified

Triclinic Labs, Inc

Physical and Analytical Chemistry Expertise

2660 Schuyler Ave, Suite A.
Lafayette, IN 47905

click for phone  |  Fax: (206) 203-1188

tricliniclabs.com

About Triclinic Labs, Inc

Triclinic Labs provides contract pharmaceutical and fine chemical solid-state development and materials characterization services. We offer complete organic and inorganic analytical services, counterfeit and contaminant analysis, method development, valdiation. and release testing, and intellectual property support. We are the global leader in solid-form screening and selection of polymorphs, salts, cocrystals, and amorphous materials for optimal preclinical, clinical, and manufacturing development. We provide amorphous formulation and stability development services using minimal materials. We are a cGMP, DEA Schedule I-V Licensed and FDA registered and inspected lab. Please visit our website for a full description of services.

Products by Triclinic Labs, Inc

By Triclinic Labs, Inc

The Search for Optimal Solid Form Properties: Our Services and Approach for Pharmaceutical and Fine Chemical Development and Crystallization Different crystalline solid forms of an active pharmaceutical ingredient (API) can have very different physico chemical properties. Those differences can... Read more »

Product Website

By Triclinic Labs, Inc

Triclinic Labs offers a comprehensive suite of services for the analysis of particle characteristics. In either a cGMP and non-GMP environment, we can fully characterize your preparation and develop methods for agency submission, routine testing, pre-clinical development, and markets release.... Read more »

Product Website

By Triclinic Labs, Inc

Whether, you require simple analytical services for materials identification, more extensive interpretation of analytical data, or development of analytical methods, we have the experience and techniques to meet your needs. Pharmaceutical (Drug Substance, Drug Product, Excipients, Raw... Read more »

Product Website

View all products »

Content by Triclinic Labs, Inc

Novel Non-Crystalline Materials Analysis: New Strategies to De-risk Amorphous Material Formulation D

Novel Non-Crystalline Materials Analysis: New Strategies to De-risk Amorphous Material Formulation D

Novel Non-Crystalline Materials Analysis: New Strategies to De-risk Amorphous Material Formulation D

By Triclinic Labs, Inc

The latest approaches for characterizing non-crystalline (amorphous) materials and determining physical stability under typical storage conditions. Amorphous forms consist of disordered arrangements of molecules that do not possess a distinguishable crystal lattice. Different forms of a drug...
Read More

Application of Low-Frequency (LF) Raman Spectroscopy to an Isoenergetic Polymorph Study

Application of Low-Frequency (LF) Raman Spectroscopy to an Isoenergetic Polymorph Study

Application of Low-Frequency (LF) Raman Spectroscopy to an Isoenergetic Polymorph Study

By Triclinic Labs, Inc

The importance of polymorphism in the pharmaceutical industry is well established. Much literature exists describing the effect of polymorphs on efficacy, the phenomenon of polymorphism, and the analytical tools available to study polymorphism in active pharmaceutical ingredients and drug...
Read More